Diabetic Ulcer Treatment Market Regional Analysis, Key Players, Revenue Expectation, Investment Opportunities, Industry Demand, and Forecast Till 2031

Kenneth Research, in its repository of market research reports, have recently added a report on Diabetic Ulcer Treatment Market which emphasizes on the latest trends, key opportunities, drivers, and the challenges associated with the growth of the market during the forecast period, i.e., 2022 – 2031. The Diabetic Ulcer Treatment Market is anticipated to grow primarily on account of the growing trade of ICT goods and services worldwide. According to the statistics by the World Bank, the exports of ICT goods globally increased from 11.164% of total goods exports in 2017 to 11.53% of total goods exports in 2019.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4  billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Diabetic Ulcer Treatment Market products.

The Global Diabetic Ulcer Treatment Market is estimated to be USD 7500 Million by 2025 at a CAGR of 8.5%.An increase in healthcare expenditure in developing countries is expected to drive the growth of the global diabetic ulcer treatment market.Strategic mergers & acquisitions are also likely to boost market growth with companies looking to strengthen their market positioning, increase their product portfolios, and improve their brand goodwill. For instance, in May 2019, 3M announced the acquisition of Acelity L.P.Inc.  and its KCI subsidiaries for approximately USD 6.7 billion. The acquisition would help 3M strengthen its position in the global diabetic ulcer treatment market.

Download Sample of This Strategic Report- https://www.kennethresearch.com/sample-request-10159190

Market Influencer

Increased spending on healthcare. Diabetic ulcer treatment accounted for an estimated hospitalization or amputation costs of USD 35,000 to USD 45,000 in Australia, Europe, and the Americas, and around USD 5,000 in developing countries.

In 2018, the worldwide GDP stood at USD 84,740.3 Billion as compared to the GDP of USD 80,144.5 Billion in 2017, marked a growth of 5.73% in 2018 over previous year according to the data quoted by International Monetary Fund. This is likely to impel the growth of Keyword market over the period 2019-2026.

The Keyword market report also focuses on the analysis on the basis of geography which includes North America (U.S. and Canada), Latin America (Mexico, Brazil, Argentina, Rest of Latin America), Europe (Germany, UK, France, Spain, Italy, NORDIC, BENELUX, Poland, Russia, Hungary, Rest of Europe), Asia Pacific (China, Japan, India, Australia, New Zealand, South Korea, Malaysia, Indonesia, Rest of Asia Pacific) and Middle East and Africa (GCC, North Africa, South Africa and Rest of Middle East and Africa). In U.S., the GDP per capita was valued at USD 62,606 in 2018 as compared to USD 59,895 marked in 2017, observed a growth of 4.53% in 2018 over previous year. Rise in GDP per capita has intensified the growth of this market in the country

Rise in the prevalence rate of diabetic foot ulcers. One of the most common complications associated with diabetes is diabetic foot ulcerations. It has a global annual incidence rate of 6.3%.The upsurge in the adoption of technological advancements in wound care products.Rising patient population and advancement in health care infrastructure.The high cost of diabetic ulcer treatments. In 2017, it was estimated that in European countries the direct and indirect expenditure in the care for patients suffering from diabetic foot ulcers is USD 13,561 annually.


By Type

Foot Ulcer: This segment consists of neuropathic ulcers, neuro-ischemic ulcers, and ischemic ulcers. This is the largest segment of the diabetic ulcer treatment market.Mouth Ulcer: This segment is estimated to hold the second-largest share of the market, owing to the high prevalence of mouth ulcer in diabetic patient.

Download Sample of This Strategic Report- https://www.kennethresearch.com/sample-request-10159190

By Treatment

Wound Care Dressings: This segment consists of hydrogels, foams, alginates, and others. This is estimated to be the largest segment of the market, because of the increasing number of diabetic patients and mounting the geriatric population.Wound Care Devices: This segment consists of ultrasound therapy, negative pressure wound therapy device (NPWT), and hyperbaric oxygen therapy (HBOT). This segment is driven by new technological advancements in healthcare.Active Therapies: This segment includes skin grafts and substitutes and topical agents. The topical agents are used for diabetic ulcers, either as a treatment for infected wounds or to prevent infection in uninfected wounds.

By End-User

Hospitals and clinics: This is the largest segment. The government support, favorable policies, and awareness campaigns initiated by governments across the globe are responsible for increasing the number of patients in hospitals and clinics. For instance, in 2016, the Government of India had launched the mDiabetes portal with the help of the World Health Organization (WHO) to spread awareness about diabetes.Ambulatory Surgical Centers: A growing segment owing to an increasing prevalence rate of diabetes and number of surgeries.Academic and Research Organization: Technology advances and research and development collaborations in medical science is driving the growth of the segment.

Request For Full Report- https://www.kennethresearch.com/sample-request-10159190

By Region

Americas: The largest regional market. As per recent reports, 30.3 million people are suffering from diabetes, which is 9.4% of the US population and almost 84.1 million adults aged 18 years or older are suffering from prediabetes, which is 33.9% of the US adult population.Europe: Europe’s 9.6% of GDP was devoted to health care in 2017. In Europe, the total expenditure spent on diabetes treatment in year 2017, was USD 207 billion. Also, the health care segment of the region is well versed, and hence, it is the second-largest market.

Asia-Pacific: The fastest-growing regional market for diabetic ulcer treatment, Asia-Pacific has the world’s largest population and fast-developing healthcare industry such as in China, India, and others. In addition, East Asia has a growing elderly population which is expected to drive the market’s growth.Middle East & Africa: The underdeveloped infrastructural chain of the region makes it very difficult for the manufactures to reach their consumers. However, if the affordability rate improves the growth of the market would be even more dynamic.

Request For Full Report- https://www.kennethresearch.com/sample-request-10159190

Key Players

Smith & Nephew PLC (UK)

Integra LifeSciences Corporation (US)

SANUWAVE Health, Inc. (US)

Cardinal Health (US)

3M (US)

Braun Melsungen AG (Germany)


ConvaTec Group PLC (UK): Offers advanced wound care under the brand names Aquacel, AVELLE, DuoDERM, Foam Lite, and Hydrofibe

Organogenesis Inc. (US)

Mölnlycke Health Care AB (Sweden)

Essity Aktiebolag (Sweden)

About Us
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.

Contact Us
Name: Kenneth research
Phone: +1 313 462 0609

Related posts

Leave a Comment